Literature DB >> 1852535

The antibody response in breast-fed and non-breast-fed infants after artificial colonization of the intestine with Escherichia coli O83.

R Lodinová-Zádníková1, M Slavíková, H Tlaskalová-Hogenová, I Adlerberth, L A Hanson, A Wold, B Carlsson, C Svanborg, L Mellander.   

Abstract

The local and systemic antibody response after oral administration of a nonenteropathogenic type 1 fimbriated Escherichia coli O83 strain was followed in nine breast-fed and eight formula-fed infants during their first 15 wk of life. Five breast-fed and six formula-fed infants were followed as controls. E. coli O83 was detected in the stools of colonized infants from d 2 after colonization and persisted in the intestine for up to 26 wk. The percentage of children successfully colonized with E. coli O83 was higher among breast-fed than among formula-fed colonized infants. Also, the O83 bacteria isolated from the breast-fed children had a higher capacity to attach to colonic epithelial cells of the HT-29 cell line than those isolated from bottle-fed infants. E. coli O83 IgA and IgM antibodies estimated by ELISA were significantly elevated in the saliva of colonized as compared with control infants 2-7 wk after colonization. IgA antibodies against O83 were also higher in the stool of colonized formula-fed infants than in formula-fed controls. The results suggest that the mucosal immune system of the newborn infant can be triggered early to produce specific antibodies against bacteria colonizing the intestine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1852535     DOI: 10.1203/00006450-199104000-00013

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  12 in total

1.  Colostrum of healthy mothers contains broad spectrum of secretory IgA autoantibodies.

Authors:  Jaroslava Pribylova; Klara Krausova; Ingrid Kocourkova; Pavel Rossmann; Klara Klimesova; Miloslav Kverka; Helena Tlaskalova-Hogenova
Journal:  J Clin Immunol       Date:  2012-07-10       Impact factor: 8.317

2.  Oral administration of probiotic bacteria (E. coli Nissle, E. coli O83, Lactobacillus casei) influences the severity of dextran sodium sulfate-induced colitis in BALB/c mice.

Authors:  A Kokesová; L Frolová; M Kverka; D Sokol; P Rossmann; J Bártová; H Tlaskalová-Hogenová
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

Review 3.  The gut as a lymphoepithelial organ: the role of intestinal epithelial cells in mucosal immunity.

Authors:  H Tlaskalová-Hogenová; M A Farré-Castany; R Stĕpánková; H Kozáková; L Tucková; D P Funda; R Barot; B Cukrowska; J Sinkora; L Mandel
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

4.  Re.: Oral administration of a certain strain of live Escherichia coli for intestinal disorders? (Infection 23 [1995] 51-54)

Authors:  J Schulze; U Sonnenborn
Journal:  Infection       Date:  1995 May-Jun       Impact factor: 3.553

5.  Case-control study of risk of dehydrating diarrhoea in infants in vulnerable period after full weaning.

Authors:  S C Fuchs; C G Victora; J Martines
Journal:  BMJ       Date:  1996-08-17

6.  Preponderance of IgM from blood lymphocytes in response to infantile rotavirus gastroenteritis.

Authors:  M Kaila; E Isolauri; E Virtanen; H Arvilommi
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

7.  Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0-6 months.

Authors:  M M Grönlund; H Arvilommi; P Kero; O P Lehtonen; E Isolauri
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-11       Impact factor: 5.747

8.  Presence of secretory IgA antibodies to an enteric bacterial pathogen in human milk and saliva.

Authors:  K A Nathavitharana; D Catty; C Raykundalia; A S McNeish
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-03       Impact factor: 5.747

9.  The early postnatal development of salivary antibody and immunoglobulin response in children orally colonized with a nonpathogenic, probiotic strain of E. coli.

Authors:  Z Vancíková; R Lodinová-Zádníková; J Radl; H Tlaskalová-Hogenová
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

10.  Effect of oral application of a probiotic E. coli strain on the intestinal microflora of children of allergic mothers during the first year of life.

Authors:  I Kocourková; R Žádníková; J Žižka; V Rosová
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.